🔎 Trials Near Me

Home › Cancro metastatico › New York

Studi clinici su Cancro metastatico nello stato di New York

111 studi su Cancro metastatico cercano partecipanti presso sedi nello stato di New York.

Città nello stato di New York

Testo ufficiale dello studio (inglese)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Roswell Park Cancer Institute, Buffalo
  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • e altri 8
In reclutamentoFase 2
Tutte le età · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07562152

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START New York Long Island LLC, Lake Success
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06270706

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07205822

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06234605

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • Roswell Park Comprehensive, Buffalo
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT05287945

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Roswell Park Cancer Institute, Buffalo
  • Columbia University - Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • e altri 1
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • Roswell Park Cancer Institute, Buffalo
  • Icahan School of Medicine at Mount Sinai, New York
  • University of Rochester Medical Center, Rochester
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  • Montefiore Medical Center-Einstein Campus, The Bronx
  • Montefiore Medical Center-Weiler Hospital, The Bronx
  • Montefiore Medical Center - Moses Campus, The Bronx
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • NYOH Albany Cancer Center, Albany
  • Hematology-Oncology Associates of Central New York, PC, Auburn
  • North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, Babylon
  • e altri 12
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • New York Oncology Hematology, Albany
  • New York Oncology Hematology, Clifton Park
  • Hematology Oncology Associates of Rockland, Nyack
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07222566

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Icahn School of Medicine at Mount Sinai, New York
  • University of Rochester Medical Center, Rochester
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06989437

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07612176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

  • Research Site, New York
  • Research Site, Stony Brook
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07007559

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05118789

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), East White Plains
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • e altri 1
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT05607108

Intratumoral N17350 in Advanced Solid Tumors

  • Roswell Park Comprehensive Cancer Center, Buffalo
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07339176

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

  • Columbia University Irving Medical Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06915753

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical College, New York
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • NYOH Albany Cancer Center, Albany
  • New York University (NYU) Brooklyn, Brooklyn
  • Memorial Sloan Kettering Cancer Center, New York
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Columbia University, New York
  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • New York University (NYU) Langone Medical Center, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  • START New York-Long Island, Lake Success
  • Memorial Sloan Kettering Cancer Center (MSKCC), New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07262619

SLV-154 Treatment of Advanced Cancers

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06771219

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Roswell Park Cancer Institute, Buffalo
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213804

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

  • NYU Langone Health Perlmutter Cancer Center, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07629960

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 set 2026 · NCT07450859

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

  • New York Oncology Hematology, P.C., Albany
  • New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
  • MSK Commack, Commack
  • e altri 7
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07227415

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • Memorial Sloan Kettering Cancer Center ( Site 0006), New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06863272

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

  • Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
  • Columbia University, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT04977453

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, New York
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 set 2026 · NCT07335497

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

  • Montefiore, The Bronx
In reclutamentoFase 1
Età 19 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07563829

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Maimonides Cancer Center, Brooklyn
  • Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success
  • Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
  • e altri 3
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06311214

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.